Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry
dc.contributor.author | Pipilis, A. | en |
dc.contributor.author | Andrikopoulos, G. | en |
dc.contributor.author | Lekakis, J. | en |
dc.contributor.author | Kalantzi, K. | en |
dc.contributor.author | Kitsiou, A. | en |
dc.contributor.author | Toli, K. | en |
dc.contributor.author | Floros, D. | en |
dc.contributor.author | Gaita, D. | en |
dc.contributor.author | Karalis, I. | en |
dc.contributor.author | Dragomanovits, S. | en |
dc.contributor.author | Kalogeropoulos, P. | en |
dc.contributor.author | Synetos, A. | en |
dc.contributor.author | Koutsogiannis, N. | en |
dc.contributor.author | Stougiannos, P. | en |
dc.contributor.author | Antonakoudis, C. | en |
dc.contributor.author | Goudevenos, J. | en |
dc.date.accessioned | 2015-11-24T19:00:32Z | |
dc.date.available | 2015-11-24T19:00:32Z | |
dc.identifier.issn | 1741-8275 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19552 | |
dc.rights | Default Licence | - |
dc.subject | Adrenergic beta-Antagonists/therapeutic use | en |
dc.subject | Aged | en |
dc.subject | Angina Pectoris/epidemiology | en |
dc.subject | Angioplasty, Balloon, Coronary | en |
dc.subject | Angiotensin II Type 1 Receptor Blockers/therapeutic use | en |
dc.subject | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | en |
dc.subject | Anticoagulants/therapeutic use | en |
dc.subject | Drug Utilization | en |
dc.subject | Female | en |
dc.subject | Greece/epidemiology | en |
dc.subject | Health Facilities/*statistics & numerical data | en |
dc.subject | *Heart Catheterization | en |
dc.subject | Heart Failure/epidemiology | en |
dc.subject | Heparin/therapeutic use | en |
dc.subject | *Hospitalization | en |
dc.subject | Humans | en |
dc.subject | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | en |
dc.subject | Male | en |
dc.subject | Myocardial Infarction/epidemiology/*therapy | en |
dc.subject | Myocardial Reperfusion | en |
dc.subject | *Outcome Assessment (Health Care) | en |
dc.subject | Platelet Aggregation Inhibitors/therapeutic use | en |
dc.subject | Recurrence | en |
dc.subject | Registries | en |
dc.subject | Shock/epidemiology | en |
dc.subject | Stroke/epidemiology | en |
dc.title | Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry | en |
heal.abstract | AIMS: To compare the treatment and outcomes of myocardial infarction patients in hospitals with and without catheterization laboratory. METHODS AND RESULTS: The Hellenic Infarction Observation Study was a countrywide registry of acute myocardial infarction, conducted during 2005-2006. The registry enrolled 1840 patients with myocardial infarction from 31 hospitals with a proportional representation of all types of hospitals and of all geographical areas. Out of these patients, 645 (35%) were admitted in 11 hospitals with and 1195 (65%) in 20 hospitals without catheterization laboratory. Patients admitted in hospitals with catheterization laboratory in comparison with patients admitted in hospitals without were younger (66+/-14 vs. 68+/-13, P<0.004) with less diabetes (27 vs. 33%, P<0.001), but without other baseline differences (female 27 vs. 25%, prior myocardial infarction 20 vs. 17%, Killip class>1 22 vs. 23%). Reperfusion rates for ST-segment elevation myocardial infarction were 67% (43% lytic, 24% primary percutaneous coronary interventions) versus 56% (55% lytic, 1% percutaneous coronary interventions; P<0.01). In-hospital outcomes in hospitals with versus in hospitals without laboratory were: mortality 6.5 versus 8.3% (NS), stroke 2.2 versus 1.1% (NS), major bleeding 1.1 versus 0.6% (NS), and heart failure 11 versus 16% (P<0.01). In multivariate regression analysis, being admitted in a hospital without catheterization laboratory was not an independent predictor of increased in-hospital mortality (odds ratio=1.18, 95% confidence interval: 0.72-1.93, P=0.505). CONCLUSION: Although the majority of acute myocardial infarction patients was admitted in hospitals without catheterization laboratory, these patients do not have a survival disadvantage, provided they are treated with lytic therapy, medical secondary prevention drugs, and eventual revascularization according to current guidelines. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1097/HJR.0b013e32831e954e | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/19188809 | - |
heal.identifier.secondary | http://cpr.sagepub.com/content/16/1/85 | - |
heal.journalName | Eur J Cardiovasc Prev Rehabil | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2009 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: